Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

RPS officially rejoins FIP after member pressure forced U-turn

The Royal Pharmaceutical Society’s (RPS) application to rejoin the International Pharmaceutical Federation (FIP) has been accepted, it has announced.

The RPS today (March 13) said that it has officially rejoined FIP, the global federation of national pharmaceutical associations.


It announced that it would apply to rejoin the body in November, after an “overwhelming majority” of its members voted in favour of doing so.

 

Read more: RPS plans to rejoin international pharmacy body in U-turn


The RPS had invited its members to share their views on whether it should rejoin FIP, after many reported being “unhappy” with its decision to withdraw from the Netherlands-based global body in March.

The U-turn decision to rejoin “reflects the RPS’s commitment to international collaboration and the advancement of the pharmacy profession”, the membership body said.



“Delighted” to rejoin



“Members told us they wanted to see us re-join FIP to further our commitment to international partnerships that support education and advocacy to develop and progress the pharmacy profession,” RPS president Professor Claire Anderson said.

 

She added that the RPS “fully recognises the importance of international collaboration and the sharing of knowledge and best practice” with colleagues across the world.

 

Read more: Do pharmacists want the RPS to rejoin FIP?

 

Professor Anderson said that the RPS is “delighted” to work with FIP again, which is “refocusing” its membership offer.

 

The bodies will work together on “opportunities for professional development and increased visibility and recognition for the pharmacy profession”, she added.

 

“Now that we have re-joined, our teams across RPS look forward to reinvigorating the close collaboration we have previously enjoyed with our colleagues both within FIP itself, and across the breadth of FIP member organisations to further our vision and mission,” RPS CEO Paul Bennett said.

 

 

“Pleased to welcome RPS back”

 

 

FIP chief executive Dr Catherine Duggan said the organisation is “pleased to welcome RPS back to the FIP family”. 

 

“RPS is an influential voice in pharmacy across GB and their re-joining will strengthen our objectives to advance pharmacy worldwide,” she added.

 

Read more: RPS quits pharmacy body that it helped found in 1912

 

Meanwhile, FIP president Dominique Jordan said that “all pharmacy bodies need to work in solidarity to advocate for the profession and improve health outcomes for patients around the world”, amid the “challenges our profession and health systems face”.

 

The RPS assembly had proposed that the RPS should once again become a FIP member from January, but its return to the global body was subject to FIP’s agreement.


Pharmacists C+D spoke to in November all supported the move to rejoin the global body, although some criticised the RPS’s decision to leave in the first place and to not consult its members about it.


Related Content

Topics

         
Pharmacist
Norfolk
£53,025

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD136854

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel